Retinyl acetate
Internal ID | 9b08029d-96c6-438b-bace-490f9392df95 |
Taxonomy | Lipids and lipid-like molecules > Prenol lipids > Retinoids |
IUPAC Name | [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate |
SMILES (Canonical) | CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCOC(=O)C)C)C |
SMILES (Isomeric) | CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/COC(=O)C)/C)/C |
InChI | InChI=1S/C22H32O2/c1-17(9-7-10-18(2)14-16-24-20(4)23)12-13-21-19(3)11-8-15-22(21,5)6/h7,9-10,12-14H,8,11,15-16H2,1-6H3/b10-7+,13-12+,17-9+,18-14+ |
InChI Key | QGNJRVVDBSJHIZ-QHLGVNSISA-N |
Popularity | 1,737 references in papers |
Molecular Formula | C22H32O2 |
Molecular Weight | 328.50 g/mol |
Exact Mass | 328.240230259 g/mol |
Topological Polar Surface Area (TPSA) | 26.30 Ų |
XlogP | 6.30 |
Atomic LogP (AlogP) | 6.08 |
H-Bond Acceptor | 2 |
H-Bond Donor | 0 |
Rotatable Bonds | 6 |
Vitamin A acetate |
Retinol acetate |
127-47-9 |
Retinol, acetate |
all-trans-Retinyl acetate |
Crystalets |
Myvak |
Myvax |
Vitamin A1 acetate |
all-trans-Retinol acetate |
There are more than 10 synonyms. If you wish to see them all click here. |
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9965 | 99.65% |
Caco-2 | + | 0.8481 | 84.81% |
Blood Brain Barrier | + | 0.9250 | 92.50% |
Human oral bioavailability | - | 0.6429 | 64.29% |
Subcellular localzation | Mitochondria | 0.6550 | 65.50% |
OATP2B1 inhibitior | - | 0.8595 | 85.95% |
OATP1B1 inhibitior | - | 0.4738 | 47.38% |
OATP1B3 inhibitior | - | 0.5699 | 56.99% |
MATE1 inhibitior | - | 0.8800 | 88.00% |
OCT2 inhibitior | - | 0.6250 | 62.50% |
BSEP inhibitior | + | 0.9686 | 96.86% |
P-glycoprotein inhibitior | - | 0.5000 | 50.00% |
P-glycoprotein substrate | - | 0.8885 | 88.85% |
CYP3A4 substrate | + | 0.6567 | 65.67% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.8852 | 88.52% |
CYP3A4 inhibition | - | 0.9420 | 94.20% |
CYP2C9 inhibition | - | 0.8729 | 87.29% |
CYP2C19 inhibition | - | 0.7811 | 78.11% |
CYP2D6 inhibition | - | 0.9110 | 91.10% |
CYP1A2 inhibition | - | 0.7514 | 75.14% |
CYP2C8 inhibition | - | 0.6660 | 66.60% |
CYP inhibitory promiscuity | - | 0.6383 | 63.83% |
UGT catelyzed | - | 0.0000 | 0.00% |
Carcinogenicity (binary) | - | 0.6528 | 65.28% |
Carcinogenicity (trinary) | Warning | 0.5486 | 54.86% |
Eye corrosion | - | 0.9400 | 94.00% |
Eye irritation | - | 0.9209 | 92.09% |
Skin irritation | + | 0.6758 | 67.58% |
Skin corrosion | - | 0.9885 | 98.85% |
Ames mutagenesis | - | 0.7923 | 79.23% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.8310 | 83.10% |
Micronuclear | - | 1.0000 | 100.00% |
Hepatotoxicity | + | 0.8148 | 81.48% |
skin sensitisation | + | 0.8040 | 80.40% |
Respiratory toxicity | + | 0.6667 | 66.67% |
Reproductive toxicity | + | 0.8556 | 85.56% |
Mitochondrial toxicity | - | 0.8000 | 80.00% |
Nephrotoxicity | + | 0.8555 | 85.55% |
Acute Oral Toxicity (c) | III | 0.6553 | 65.53% |
Estrogen receptor binding | + | 0.6414 | 64.14% |
Androgen receptor binding | - | 0.5496 | 54.96% |
Thyroid receptor binding | + | 0.7066 | 70.66% |
Glucocorticoid receptor binding | - | 0.5282 | 52.82% |
Aromatase binding | + | 0.8466 | 84.66% |
PPAR gamma | + | 0.5640 | 56.40% |
Honey bee toxicity | - | 0.8862 | 88.62% |
Biodegradation | - | 0.8500 | 85.00% |
Crustacea aquatic toxicity | - | 0.6555 | 65.55% |
Fish aquatic toxicity | + | 0.9946 | 99.46% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL1293255 | P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD+] |
6309.6 nM |
Potency |
via CMAUP
|
CHEMBL3577 | P00352 | Aldehyde dehydrogenase 1A1 |
14125.4 nM 22387.2 nM 18869.9 nM |
Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP |
CHEMBL340 | P08684 | Cytochrome P450 3A4 |
25118.9 nM 25118.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL4159 | Q99714 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
39810.7 nM |
Potency |
via CMAUP
|
CHEMBL1293224 | P10636 | Microtubule-associated protein tau |
12589.3 nM 8912.5 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1697668 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 |
2238.72 nM |
IC50 |
PMID: 23571415
|
CHEMBL1743121 | Q9NPD5 | Solute carrier organic anion transporter family member 1B3 |
5011.87 nM |
IC50 |
PMID: 23571415
|
CHEMBL1075138 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 |
3548.1 nM |
Potency |
via CMAUP
|
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 94.35% | 96.09% |
CHEMBL230 | P35354 | Cyclooxygenase-2 | 94.18% | 89.63% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 94.00% | 91.11% |
CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 92.94% | 95.50% |
CHEMBL2061 | P19793 | Retinoid X receptor alpha | 92.86% | 91.67% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 92.32% | 86.33% |
CHEMBL1870 | P28702 | Retinoid X receptor beta | 91.00% | 95.00% |
CHEMBL1937 | Q92769 | Histone deacetylase 2 | 88.81% | 94.75% |
CHEMBL2004 | P48443 | Retinoid X receptor gamma | 88.37% | 100.00% |
CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 88.15% | 91.71% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 87.19% | 95.56% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 86.86% | 94.45% |
CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 82.08% | 92.62% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 80.48% | 96.00% |
CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 80.45% | 98.75% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Nelumbo nucifera |
PubChem | 638034 |
NPASS | NPC226066 |
ChEMBL | CHEMBL486193 |